09:00 EST Atara Biotherapeutics (ATRA) trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATRA:
- Atara Biotherapeutics remains eligible for $60M milestone payment
- Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
- Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
- Atara Biotherapeutics trading halted, news pending
- Twelve option delistings on December 23rd
Questions or Comments about the article? Write to editor@tipranks.com